<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tan C</submitter><funding>Howard Hughes Medical Institute</funding><funding>Burroughs Wellcome Fund</funding><funding>NIAID NIH HHS</funding><funding>Rheumatology Research Foundation</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases</funding><funding>Uehara Memorial Foundation</funding><funding>NIAMS NIH HHS</funding><funding>Cancer Research Institute</funding><funding>Chan–Zuckerberg Biohub; Innovative Genomics Institute; Parker Institute for Cancer Immunotherapy</funding><funding>Division of Intramural Research, National Institute of Allergy and Infectious Diseases</funding><pagination>1267-1279</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8081071</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(10)</volume><pubmed_abstract>Antigen stimulation (signal 1) triggers B cell proliferation and primes B cells to recruit, engage and respond to T cell help (signal 2). Failure to receive signal 2 within a defined time window results in B cell apoptosis, yet the mechanisms that enforce dependence on co-stimulation are incompletely understood. Nr4a1-3 encode a small family of orphan nuclear receptors that are rapidly induced by B cell antigen receptor stimulation. Here, we show that Nr4a1 and Nr4a3 play partially redundant roles to restrain B cell responses to antigen in the absence of co-stimulation and do so, in part, by repressing the expression of BATF and, consequently, MYC. The NR4A family also restrains B cell access to T cell help by repressing expression of the T cell chemokines CCL3 and CCL4, as well as CD86 an</pubmed_abstract><journal>Nature immunology</journal><pubmed_title>NR4A nuclear receptors restrain B cell responses to antigen when second signals are absent or limiting.</pubmed_title><pmcid>PMC8081071</pmcid><funding_grant_id>R01 AR069520</funding_grant_id><funding_grant_id>R01AR069520</funding_grant_id><funding_grant_id>5T32AI007334-28</funding_grant_id><funding_grant_id>HHMI Medical Research Fellows program</funding_grant_id><funding_grant_id>Lloyd J. Old STAR grant</funding_grant_id><funding_grant_id>Innovative Research Award</funding_grant_id><funding_grant_id>Career Award for Medical Scientists</funding_grant_id><funding_grant_id>T32 AI007334</funding_grant_id><funding_grant_id>R01 AI148487</funding_grant_id><pubmed_authors>Hiwa R</pubmed_authors><pubmed_authors>Brooks JF</pubmed_authors><pubmed_authors>Noviski M</pubmed_authors><pubmed_authors>Hibiya K</pubmed_authors><pubmed_authors>Huizar J</pubmed_authors><pubmed_authors>Tan C</pubmed_authors><pubmed_authors>Zikherman J</pubmed_authors><pubmed_authors>Garcia J</pubmed_authors><pubmed_authors>Heyn C</pubmed_authors><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Vykunta V</pubmed_authors><pubmed_authors>Mueller JL</pubmed_authors><pubmed_authors>Marson A</pubmed_authors></additional><is_claimable>false</is_claimable><name>NR4A nuclear receptors restrain B cell responses to antigen when second signals are absent or limiting.</name><description>Antigen stimulation (signal 1) triggers B cell proliferation and primes B cells to recruit, engage and respond to T cell help (signal 2). Failure to receive signal 2 within a defined time window results in B cell apoptosis, yet the mechanisms that enforce dependence on co-stimulation are incompletely understood. Nr4a1-3 encode a small family of orphan nuclear receptors that are rapidly induced by B cell antigen receptor stimulation. Here, we show that Nr4a1 and Nr4a3 play partially redundant roles to restrain B cell responses to antigen in the absence of co-stimulation and do so, in part, by repressing the expression of BATF and, consequently, MYC. The NR4A family also restrains B cell access to T cell help by repressing expression of the T cell chemokines CCL3 and CCL4, as well as CD86 an</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Oct</publication><modification>2026-04-30T03:08:59.466Z</modification><creation>2022-02-10T08:17:36.494Z</creation></dates><accession>S-EPMC8081071</accession><cross_references><pubmed>32868928</pubmed><doi>10.1038/s41590-020-0765-7</doi></cross_references></HashMap>